Gregory C. Rigdon

Corporate Officer/Principal at Neusentis, Inc.

Health Technology

Consumer Services

Gregory C. Rigdon active positions

Companies	Position	Start	End
Neusentis, Inc. Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.	Corporate Officer/Principal	31/12/1996	-

Texas Tech University

Doctorate Degree

International

United States

Operational

Corporate Officer/Principal	1
Doctorate Degree	1

Sectoral

Health Technology	2
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	1
Neusentis, Inc. Neusentis, Inc. Pharmaceuticals: MajorHealth Technology Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.	Health Technology

Private companies

Health Technology